October 17, 2019
  • October 17, 2019
Breaking News
  • Home
  • Kadmon Holdings

Tag Archives

Healthcare Gainers: Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Odonate Therapeutics, Inc. (NASDAQ:ODT), Kadmon Holdings, Inc. (NYSE:KDMN)

by on June 27, 2019 0
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced the completion of target enrollment of 198 participants for its pivotal Phase 3 registration trial (“REVEAL 1”) of VGX-3100, a novel DNA-based immunotherapy being tested to treat cervical dysplasia caused by human papillomavirus (HPV). Left untreated, cervical dysplasia can progress to cervical cancer. If approved, VGX-3100 would be the first... Read More